Welcome to your daily dose of digital health news and updates. Stay informed and ahead of the curve with these key insights.
👇 News
💫 An international clinical trial is exploring a new synthetic formulation of the psychedelic substance 5-MeO-DMT for Treatment Resistant Depression (TRD) in a new London location. Clerkenwell Health has partnered with Beckley Psytech to conduct the study.
👍 A group of experts suggests that AI tools in healthcare should be regulated based on their ability to improve patient outcomes, as discussed in a recent Viewpoint article published by JAMA.
😬 Researchers in Wales are launching the Persistent Pain Project to address the growing issue of persistent pain. The study is made possible through HealthWise Wales, an online research registry and data collection platform.
👴 Lilli, a SaaS company utilizing proactive lifestyle monitoring, has raised £8.2 million for its innovative technology that provides insights into wellbeing and home activities to support better health outcomes and reduce hospital visits.
🧬 Bioscientia’s human genetics division has introduced a clinical long-read whole-genome sequencing test for certain sensory disorders, with plans to expand to other inherited conditions in the future.
❓ Did you know that
Over a fifth of straight Brits believe they are unlikely to contract HIV, despite rising cases among heterosexuals, according to data released at the start of HIV testing week.
📖 What we’re reading
The US Supreme Court will consider whether Covid misinformation is protected free speech, as reported by STAT.
🚨 This week’s events
8-9 February, Birmingham – HSJ Digital Transformation Summit
